Transactions under Novozymes’ stock buyback program

As of February 20, Novozymes has purchased an accumulated 160,000 shares with a transaction value of DKK 39,6 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.

​Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2014.

The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:

 
Number
 of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
 
February 17, 2014
42,000
 246.38
10,348,026
February 18, 2014
40,000
 247.14
9,885,671
February 19, 2014
40,000
 249.07
9,962,890
February 20, 2014
38,000
 247.74
9,414,193
Total accumulated under the program
160,000
 
39,610,780

In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 54,390 B shares in the period from February 17 to February 20, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.

Following the transactions stated above, Novozymes owns a total of 4,647,822 treasury shares, corresponding to 1.5% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.

 

Contact information

Investor Relations:
 
 
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
 
 
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+45 3077 0236
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282
Poonam Kapila (India)
+91 991 082 2339